Physician profile
Matthew Carmichael
NPI 1871820852
$3,502.75
in general payments reported to CMS, 2019-2025
19 companies · $601 in 2025
The $601 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $861 · 2020: $363 · 2021: $439 · 2022: $730 · 2023: $321 · 2024: $188 · 2025: $601.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,110.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,109.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,374.73 | 2019-2023 | Hemopore, Scopis Ent |
| Inspire Medical Systems, INC. | $1,104.88 | 2019-2025 | Inspire |
| Optinose US, INC. | $298.62 | 2019-2025 | |
| Aerin Medical INC. | $150.16 | 2019-2025 | |
| Genzyme Corporation | $135.24 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $122.33 | 2019-2023 | Dupixent |
| Lilly USA, LLC | $101.66 | 2025 | Zepbound |
| Davol INC. | $26.01 | 2023 | Arista Ah Flexitip |
| Acclarent, INC | $21.46 | 2020 | |
| Intersect Ent, INC. | $20.09 | 2019 | |
| Alk-Abello, INC | $19.01 | 2022 | |
| Acera Surgical, INC. | $18.98 | 2025 | Restrata Wound Matrix |
| Astrazeneca Pharmaceuticals LP | $18.19 | 2025 | Tezspire |
| Novartis Pharmaceuticals Corporation | $17.40 | 2019 | |
| Paratek Pharmaceuticals, INC. | $16.02 | 2025 | Xhance |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $15.42 | 2024 | Nucala |
| Kaleo, INC. | $15.01 | 2021 | |
| Resmed Corp | $14.83 | 2024 | |
| Olympus America INC. | $12.71 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Carmichael listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.